🇺🇸 FDA
Patent

US 12318457

Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof

granted A61KA61K31/542A61K31/7016

Quick answer

US patent 12318457 (Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof) held by GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/542, A61K31/7016, A61K47/549, A61K47/65